Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

A holistic treatment method effectively treated alopecia totalis without major side effects.

Blocking certain proteins on immune cells may help treat alopecia areata.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

MVP treatment is effective and safe for recurrent breast cancer.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Hair restoration can cause severe seizures due to combined drug toxicity.

Dutasteride injections may be a future option for treating hair loss.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Some drugs used to treat inflammation may cause hair loss.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Long-term use of finasteride may cause breast cancer in men.

Mitoquinone protects heart cells from doxorubicin damage and slightly boosts its effect on prostate cancer cells.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

EGFR inhibitors can cause unusual localized hair growth.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

A new compound shows promise as a topical treatment for hair loss.

Selenium shows promise in preventing and controlling prostate cancer.